Portal vein thrombosis related to Cassia angustifolia

References

• E Leng-Peschlow. (1992). The importance of senna products. Pharmacol 44 (suppl. 1):1–2.
   Google Scholar
• KW Heaton, and HA Cripps. (1993). Straining at stool and laxative taking in an English population. Dig Dis Sci 38 (6):1004–8.
   PubMed Web of Science ®Google Scholar
• J Lemli. (1988). Metabolism of sennosides—an overview. Pharmacol 36 (suppl. 1):126–128.
   PubMedGoogle Scholar
• A Chevallier. Encyclopedia of Medicinal Plants. DK Publishing, New York, (1996), 72.
   Google Scholar
• C Newall, LA Anderson, and JD Phillipson. Herbal Medicines. Pharmaceutical Press, London, (1996), 243–44.
   Google Scholar
• N Bisset. Herbal Drugs and Phytopharmaceuticals. CRC Press Inc, StuttgartGermany, (1994), 463–66.
   Google Scholar
• MR Van der Ohe, M Camilleri, LK Kvols, and GM Thomforde. (1993). Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. N Engl J Med 329:1073–8.
   PubMed Web of Science ®Google Scholar
• A Van Hoestenberghe, P De Witte, K Geboes, H Eyssen, G Nijs, and J Lemli. (1992). The effect of rhein and rhein anthrone on intestinal fluid transport and on large intestine transit in germ free rats. Eur J Pharmacol 212:121–3.
   PubMed Web of Science ®Google Scholar
• BA Van Gorkom, EG De Vries, A Karrenbeld, and JH Kleibeuker. (1999r). Review article: Anthranoid laxatives and their potential carcinogenic effects. Aliment Pharmacol Ther. 13 (4):443–52.
   PubMed Web of Science ®Google Scholar
• . Herbal Medicine: Expanded Commission E MonographsM Blumenthal, J Brinckmann, and A Goldberg. Integrative Medicine Communications, Newton, MA, (2000).
   Google Scholar
• HA Spiller, ML Winter, JA Weber, EP Krenzelok, DL Anderson, and ML Ryan. (2003). Skin breakdown and blisters from senna-containing laxatives in young children. Ann Pharmacother. 37 (5):636–9.
   PubMed Web of Science ®Google Scholar
• JM Gattuso, and MA Kamm. (1994). Adverse effects of drugs used in the management of constipation and diarrhoea. Drug Safety 10 (1):47–65.
   PubMed Web of Science ®Google Scholar
• P Faber, and A Strenge-Hesse. (1989). Senna-containing laxatives: Excretion in the breast milk?. Geburtshilfe Frauenheilkd 49 (11):958–62.
   PubMed Web of Science ®Google Scholar
• http://aappolicy.aappublications.org/cgi/content/full/pediatrics;108/3/776#T6,2005 American Academy of Pediatrics. The transfer of drugs and other chemicals in to human milk..
   Google Scholar
• U Mengs. (1986). Reproductive toxicological investigations with sennosides. Arzneimittelforschung. 36:1355–8.
   PubMed Web of Science ®Google Scholar
• P Faber, and A Strenge-Hesse. (1988). Relevance of rhein excretion into breast milk. Pharmacol 36 (suppl. 1):212–20.
   PubMedGoogle Scholar
• NL Roberts. (2005). CMT Pharmacology 101. Journal of the American Association for Medical Transcription 24 (1):31–33.
   Google Scholar
• http://www.fda.gov/OHRMS/DOCKETS/dailys/03/Aug03/081503/78n-0036l-bkg0004-08-tab10-vol1.pdf U.S. Food and Drug Administration..
   Google Scholar
• . The Complete Commission E Monographs: Therapeutic Guide to Herbal MedicinesM Blumenthal, WR Busse, A Goldberg, J Gruenwald, T Hall, CW Riggins, and RS Rister. Integrative Medicine Communications, Boston, MA, (1998), 204–8.
   Google Scholar
• F Stickel, and D Schuppan. (2007). Herbal medicine in the treatment of liver diseases. Dig Liver Dis. 39 (4):293–304.
   PubMedGoogle Scholar
• A Sonmez, MI Yilmaz, R Mas, A Ozcan, B Celasun, T Dogru, A Taslipinar, and IH Kocar. (2005). Subacute cholestatic hepatitis likely related to the use of senna for chronic constipation. Acta Gastroenterol Belg 68 (3):385–7.
   PubMed Web of Science ®Google Scholar
• F Stickel, HK Seitz, EG Hahn, and D Schuppan. (2001). Liver toxicity of drugs of plant origin. Z Gastroenterol 39 (3):225–32.234–7.
   PubMedGoogle Scholar
• GJ Webster, AK Burroughs, and SM Riordan. (2005). Review article: portal vein thrombosis-new insights into aetiology and management. Aliment Pharmacol Ther 21 (1):1–9.
   PubMed Web of Science ®Google Scholar
• J Pati, M Srivastava, and P Sahni. (2003). Extra hepatic portal vein thrombosis in a child associated with lupus anticoagulant. J Trop Pediatr 49:191–2.
   PubMed Web of Science ®Google Scholar
• Y Hirohato, A Murata, S Abe, and M Otsuki. (2001). Portal vein thrombosis associated with antiphospholipid syndrome. J Gastroenterol 36:574–8.
   PubMed Web of Science ®Google Scholar
• L Brady, D Magilavy, and D Black. (1996). Portal vein thrombosis associated with antiphospholipid antibodies in a child. J Pediatr Gastroenterol Nutr 23:470–3.
   PubMed Web of Science ®Google Scholar
• R Arav-Boger, S Reif, and Y Bujanover. (1995). Portal vein thrombosis caused by protein C and protein S deficiency associated with cytomegalovirus infection. J Pediatr 126:586–8.
   PubMed Web of Science ®Google Scholar
• C Seixas, G Hessel, C Ribeiro, V Arruda, and J Annichino-Bizzacchi. (1997). Factor V Leiden is not common in children with portal vein thrombosis. Thromb Haemost 77:258–61.
   PubMed Web of Science ®Google Scholar
• C Seixas, G Hessel, L Siqueira, T Machada, A Gallisoni, and J Annichino-Bizzacchi. (1998). Study of hemostasis in pediatric patients with portal vein thrombosis. Haematologica 83:946–60.
   PubMedGoogle Scholar
• V Ahuja, N Marwaha, Y Chawla, and J Dilawari. (1999). Coagulation abnormalities in idiopathic portal vein thrombosis. J Gastroenterol Hepatol 14:1210–1.
   PubMed Web of Science ®Google Scholar
• HLA Janssen, A Wijnhoud, EB Haagsma, M van Uum, CMJ van Nieuwkerk, RP Adang, RAFM Chamuleau, J Van Hattum, FP Vleggaar, BE Hansen, FR Rosendaal, and B Van Hoek. (2001). Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 49:720–4.
   PubMed Web of Science ®Google Scholar
• MH Denninger, Y Chait, N Casadevall, S Hillaire, MC Guillin, A Bezeaud, S Erlinger, J Briere, and D Valla. (2000). Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors. Hepatology 31:587–91.
   PubMed Web of Science ®Google Scholar
• B Vanderperren, M Rizzo, L Angenot, V Haufroid, M Jadoul, and P Hantson. (2005). Acute liver failure with renal impairment related to the abuse of senna anthraquinone glycosides. Ann Pharmacother 39 (7–8):1353–7.
   PubMed Web of Science ®Google Scholar
• U Beuers, U Spengler, and G Pape. (1991). Hepatitis after chronic abuse of senna. Lancet 337:372–3.
   PubMed Web of Science ®Google Scholar
• J Westendorf, B Marquardt, M Poginski, J Dominiak, H Schmidt, and H Marquardt. (1990). Genotoxicity of naturally occurring hydroxyanthraquinones. Mutat Res 240:1–12.
   PubMed Web of Science ®Google Scholar
• A Heidemann, HG Miltenburger, and U Mengs. (1993). The genotoxicity status of senna. Pharmacol 47 (Suppl 1):178–186.
   PubMedGoogle Scholar
• CP Siegers. (1992). Anthranoid laxatives and colorectal cancer. Trends Pharmacol Sci 13:229–231.
   PubMed Web of Science ®Google Scholar
• J Westendorf. (1993). Pharmakologische und toxikologische Bewertung von Anthranoiden. Pharm Z 138:3891–3902.
   Google Scholar
• GA Kune. (1993). Laxative use not a risk for colorectal cancer: data from the melbourne colorectal cancer study. Z Gastroenterol 31:140–143.
   PubMed Web of Science ®Google Scholar
• G Nusko, B Schneider, G Müller, J Kusche, and EG Hahn. (1993). Retrospective study on laxative use and melanosis coli as risk factors for colorectal neoplasma. Pharamcol 47 (suppl. 1):234–241.
   Google Scholar
• A Lyden-Sokolowski, A Nilsson, and P Sjoberg. (1993). Two-year carcinogenicity study with sennosides in the rat: Emphasis on gastro-intestinal alterations. Pharmacol 47 (suppl. 1):209–215.
   PubMedGoogle Scholar
• P Prandoni. (2006). Acquired risk factors of venous thromboembolism in medical patients. Pathophysiol Haemost Thromb 35 (1–2):128–32.
   PubMed Web of Science ®Google Scholar
• EF Mammen. (1992). Pathogenesis of venous thrombosis. Chest 102 (6 suppl):640S–644S.
   PubMed Web of Science ®Google Scholar
• N Hidajat, H Stobbe, V Griesshaber, R Felix, and RJ Schroder. (2005). Imaging and radiological interventions of portal vein thrombosis. Acta Radiol 46 (4):336–43.
   PubMed Web of Science ®Google Scholar
• N Hidajat, H Stobbe, V Griesshaber, RJ Schroder, and R Felix. (2005). Portal vein thrombosis: Etiology, diagnostic strategy, therapy and management. Vasa 34 (2):81–92.
   PubMedGoogle Scholar
• A Tateishi, H Mitsui, T Oki, J Morishita, H Maekawa, N Yahagi, T Maruyama, M Ichinose, S Ohnishi, Y Shiratori, M Minami, S Kontetsu, N Hori, T Watanabe, H Nagawa, and M Omata. (2001). Extensive mesenteric vein and portal vein thrombosis successfully treated by thrombolysis and anticoagulation. J Gastroenterol Hepatol 16:1429–33.
   PubMed Web of Science ®Google Scholar
• B Condat, F Pessione, M Denninger, S Hillaire, and D Valla. (2000). Recent portal or mesenteric venous thrombosis: Increased recognition and frequent recanalisation on anticoagulant therapy. Hepatology 32:466–70.
   PubMed Web of Science ®Google Scholar
• B Condat, F Pessione, S Hillaire, M Denninger, M Guillin, M Poliquin, A Hadengue, S Erlinger, and D Valla. (2001). Current outcome of portal vein thrombosis in adults: Risk and benefit of anticoagulant therapy. Gastroenterology. 120:490–7.
   PubMed Web of Science ®Google Scholar